⌘K

Login Start Free

Home/Filings/4/0000899243-22-009841

4//SEC Filing

AHMED NADIM 4

Accession 0000899243-22-009841

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 9:50 PM ET

Size

5.6 KB

Accession

0000899243-22-009841

Insider Transaction Report

Form 4

Period: 2022-03-05

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Award
Performance Stock Unit
2022-03-05+215,000→ 215,000 total
Exp: 2025-03-05→ Common Stock (215,000 underlying)

Footnotes (1)

[F1]Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer. The performance stock units vest upon the Issuer's common stock achieving a specified price per share.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 9:50 PM ET
Size: 5.6 KB

View on SEC.gov